To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STARD7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
508 supporting clones for gene STARD7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CF993885 Human Placenta, placenta .a 1 to 668 37 to 701   tiling clone,   671/701
(95 %)
6 diff
(99.2 %id)
AL542720 placenta .a 5 to 1132 1 to 1113       1113/1121
(99 %)
28 diff
(97.6 %id)
TI_44342818   .a 9 to 701 122 to 814       693/846
(81 %)
6 diff
(99.3 %id)
CN394859 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 11 to 603 1 to 593       593/593
(100 %)
0 diff
(100 %id)
NM_020151.3   .a 11 to 3387 1 to 3377 exact RefSeq, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3377/3377
(100 %)
0 diff
(100 %id)
BG699425 brain, hippocampus .a 14 to 808 1 to 791       791/791
(100 %)
14 diff
(98.3 %id)
BI457913 brain, hypothalamus .a 14 to 775 1 to 763       763/769
(99 %)
10 diff
(98.7 %id)
CF593569 Human Placenta, placenta .a 21 to 740 29 to 751       723/848
(85 %)
10 diff
(98.9 %id)
TI_44171721   .a 24 to 735 91 to 808       718/808
(88 %)
10 diff
(98.8 %id)
BE893734 melanotic melanoma, skin .a 25 to 88 1 to 64       64/64
(100 %)
0 diff
(100 %id)
TI_44168940   .a 25 to 684 56 to 717       662/717
(92 %)
6 diff
(99.2 %id)
BE883689 leiomyosarcoma, uterus .a 27 to 88 1 to 63       63/63
(100 %)
1 diff
(98.5 %id)
BC008894 Skin, melanotic melanoma. .a 28 to 3387 1 to 3358   available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3358/3358
(100 %)
1 diff
(100.0 %id)
BC013279 Skin, melanotic melanoma. .a 28 to 3387 1 to 3358   available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3358/3358
(100 %)
1 diff
(100.0 %id)
BC003028 Skin, melanotic melanoma. .a 28 to 3387 1 to 3358 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3358/3358
(100 %)
1 diff
(100.0 %id)
BE302550 melanotic melanoma, skin .a 28 to 468 1 to 440   available from MGC,   440/440
(100 %)
1 diff
(99.8 %id)
CR989208 T-Lymphocytes .a 30 to 447 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BQ941159 epidermoid carcinoma, cell line, lung .a 31 to 959 1 to 940       940/948
(99 %)
17 diff
(98.3 %id)
BC014274 Lymph, Burkitt lymphoma .a 32 to 3387 1 to 3356 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3356/3356
(100 %)
1 diff
(100.0 %id)
CN394856 embryonic stem cells, cell lines H1, H7, andH9 .a 35 to 673 1 to 639       639/639
(100 %)
0 diff
(100 %id)
CX164460 human embryonic stem cells differentiated toan early endodermal cell type .a 36 to 794 1 to 759       759/759
(100 %)
0 diff
(100 %id)
BC032106 Skin, melanotic melanoma. .a 37 to 3387 1 to 3350 exact available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3350/3350
(100 %)
2 diff
(100.0 %id)
BG177499 lymph, lymphoma, cell line .a 37 to 108 1 to 74       74/74
(100 %)
2 diff
(97.3 %id)
CA396289 eye, RPE/choroid .a 38 to 447 1 to 410       410/410
(100 %)
0 diff
(100 %id)
BQ066690 lymph, lymphoma, cell line .a 38 to 822 1 to 799       799/1052
(75 %)
30 diff
(97.2 %id)
BQ217643 large cell carcinoma, lung .a 39 to 838 1 to 806       806/1117
(72 %)
22 diff
(98.1 %id)
TI_154153412   .a 39 to 652 79 to 692       614/614
(100 %)
27 diff
(95.7 %id)
CN394858 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 45 to 430 1 to 386       386/386
(100 %)
0 diff
(100 %id)
DB474043 hippocampus .a 45 to 491 1 to 447       447/447
(100 %)
7 diff
(98.5 %id)
BC012793 Uterus, leiomyosarcoma .a 47 to 3387 1 to 3338 exact available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3338/3338
(100 %)
4 diff
(99.9 %id)
AL040495 testis .a 47 to 775 1 to 724       724/727
(99 %)
4 diff
(99.5 %id)
BF026141 melanotic melanoma, skin .a 47 to 781 1 to 735       735/736
(99 %)
18 diff
(97.6 %id)
TI_154159067   .a 47 to 548 81 to 584       504/505
(99 %)
27 diff
(94.7 %id)
BQ071756 brain, neuroblastoma, cell line .a 48 to 841 1 to 802       802/1028
(78 %)
24 diff
(97.7 %id)
BC014076 Brain, neuroblastoma .a 51 to 3387 1 to 3338 R140P available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3338/3338
(100 %)
5 diff
(99.9 %id)
BM475191 duodenal adenocarcinoma, cell line, small intestine .a 51 to 522 124 to 605       482/1201
(40 %)
23 diff
(98.1 %id)
CN394874 embryonic stem cells, cell lines H1, H7, andH9 .a 52 to 417 1 to 366       366/366
(100 %)
0 diff
(100 %id)
CN394868 embryonic stem cells, cell lines H1, H7, andH9 .a 56 to 431 1 to 376       376/376
(100 %)
0 diff
(100 %id)
TI_154153367   .a 56 to 659 80 to 683       604/604
(100 %)
19 diff
(96.9 %id)
BG335467 choriocarcinoma, placenta .a 60 to 777 1 to 716       716/860
(83 %)
25 diff
(97.1 %id)
BC012774 Placenta, choriocarcinoma .a 61 to 3392 1 to 3329 exact available from MGC,   3329/3329
(100 %)
4 diff
(99.9 %id)
BU556975 ovary, teratocarcinoma, cell line .a 63 to 825 1 to 768       768/964
(79 %)
20 diff
(98.0 %id)
BU855679 ovary, teratocarcinoma, cell line .a 63 to 839 1 to 780       780/993
(78 %)
12 diff
(98.8 %id)
BM810532 astrocytoma grade IV, cell line, brain .a 66 to 963 1 to 898       898/1072
(83 %)
9 diff
(99.2 %id)
BQ670008 epidermoid carcinoma, cell line, salivary gland .a 66 to 821 1 to 767       767/914
(83 %)
30 diff
(96.8 %id)
BU849821 ovary, teratocarcinoma, cell line .a 66 to 961 1 to 896       896/931
(96 %)
29 diff
(96.9 %id)
BG762712 melanotic melanoma, high MDR (cell line), skin .a 67 to 801 1 to 734       734/734
(100 %)
22 diff
(97.1 %id)
BQ062935 lymph, lymphoma, cell line .a 67 to 1010 1 to 954       951/1022
(93 %)
26 diff
(97.5 %id)
BM927533 lymph, lymphoma, cell line .a 69 to 912 1 to 850       850/1144
(74 %)
17 diff
(98.6 %id)
BQ055168 lymph, lymphoma, cell line .a 69 to 1015 1 to 952       952/1032
(92 %)
12 diff
(98.9 %id)
BQ064010 lymph, lymphoma, cell line .a 69 to 696 1 to 629       629/1311
(47 %)
9 diff
(99.4 %id)
BQ066487 lymph, lymphoma, cell line .a 69 to 838 1 to 772       772/1033
(74 %)
9 diff
(99.2 %id)
BQ881381 lymph, lymphoma, cell line .a 69 to 841 1 to 782       782/942
(83 %)
24 diff
(97.5 %id)
AF270647   .a 76 to 3387 1 to 3303 R54P V56S L57P L58R G59P ... AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3303/3303
(100 %)
8 diff
(99.8 %id)
BQ919383 large cell carcinoma, lung .a 76 to 910 1 to 848       848/932
(90 %)
15 diff
(98.4 %id)
DR759597 embryonic stem .a 118 to 975 1 to 858       858/858
(100 %)
3 diff
(99.7 %id)
CN394861 embryonic stem cells, cell lines H1, H7, andH9 .a 143 to 722 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BU846088 ovary, teratocarcinoma, cell line .a 238 to 1068 1 to 835       835/900
(92 %)
11 diff
(98.8 %id)
BU846140 ovary, teratocarcinoma, cell line .a 238 to 1071 1 to 845       845/949
(89 %)
24 diff
(97.5 %id)
BU931993 ovary, teratocarcinoma, cell line .a 238 to 1057 1 to 831       828/959
(86 %)
20 diff
(98.0 %id)
BQ643288 lymph, lymphoma, cell line .a 244 to 1010 1 to 769       769/955
(80 %)
18 diff
(98.2 %id)
CN394876 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 265 to 403 1 to 139       139/139
(100 %)
0 diff
(100 %id)
CN394872 embryonic stem cells, cell lines H1, H7, andH9 .a 272 to 479 1 to 208       208/208
(100 %)
0 diff
(100 %id)
CN394863 embryonic stem cells, cell lines H1, H7, andH9 .a 286 to 408 1 to 123       123/123
(100 %)
0 diff
(100 %id)
BQ941873 large cell carcinoma, lung .a 316 to 1195 1 to 880       880/881
(99 %)
16 diff
(98.2 %id)
BF980655 duodenal adenocarcinoma, cell line, small intestine .a 331 to 1041 1 to 723       723/1142
(63 %)
16 diff
(98.6 %id)
BX415247 thymus .a 407 to 1237 1 to 827       827/827
(100 %)
11 diff
(98.7 %id)
BG699175 brain, hippocampus .a 509 to 1254 1 to 746       746/749
(99 %)
8 diff
(99.0 %id)
BG699567 brain, hippocampus .a 546 to 1156 1 to 616       616/623
(98 %)
25 diff
(96.0 %id)
BG330515 large cell carcinoma, lung .a 554 to 1252 1 to 700       700/869
(80 %)
22 diff
(97.5 %id)
TI_57184242   .a 554 to 1254 21 to 718       698/722
(96 %)
17 diff
(97.7 %id)
BQ940878 large cell carcinoma, lung .a 557 to 1430 1 to 891       891/896
(99 %)
11 diff
(98.8 %id)
BE779485 eye, retinoblastoma .a 559 to 1249 1 to 684       684/905
(75 %)
29 diff
(96.8 %id)
BG721224 testis .a 559 to 1254 6 to 702       697/707
(98 %)
17 diff
(97.6 %id)
BI768002 pooled lung and spleen .a 561 to 1254 1 to 691       691/695
(99 %)
12 diff
(98.3 %id)
BG324998 Kidney, renal cell adenocarcinoma .a 571 to 1149 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
CN394862 embryonic stem cells, cell lines H1, H7, andH9 .a 573 to 979 1 to 407       407/407
(100 %)
0 diff
(100 %id)
BQ933380 large cell carcinoma, lung .a 573 to 1147 1 to 575       575/851
(67 %)
11 diff
(98.8 %id)
BG699481 brain, hippocampus .a 578 to 1294 1 to 713       713/713
(100 %)
10 diff
(98.6 %id)
DB464472 hippocampus .a 586 to 1011 1 to 423       423/423
(100 %)
33 diff
(92.2 %id)
BI755712 brain .a 592 to 1373 1 to 782       782/783
(99 %)
2 diff
(99.8 %id)
TI_57217131   .a 592 to 1373 37 to 818       782/819
(95 %)
8 diff
(99.1 %id)
AK291190   .a 629 to 2123 1 to 1496       1496/1496
(100 %)
2 diff
(99.9 %id)
TI_1948074615   .a 637 to 1160 137 to 663       527/1358
(38 %)
27 diff
(98.1 %id)
TI_1948074803   .a 637 to 1528 130 to 1026   fully sequenced,   897/1026
(87 %)
40 diff
(96.2 %id)
TI_1948074989   .a 637 to 1502 129 to 1003       875/1310
(66 %)
31 diff
(97.7 %id)
AK054615 adrenal gland .a 645 to 3387 1 to 2743   available from FLJ,   2743/2743
(100 %)
7 diff
(99.8 %id)
BG703868 brain, hippocampus .a 651 to 1365 1 to 717       717/744
(96 %)
13 diff
(98.3 %id)
DB471470 hippocampus .a 658 to 1151 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BM561658 blood, natural killer cells, cell line .a 660 to 1664 1 to 1010       1010/1032
(97 %)
39 diff
(96.3 %id)
BF797190 lymph, lymphoma, cell line .a 668 to 1437 1 to 766       766/942
(81 %)
23 diff
(97.6 %id)
BG703737 brain, hippocampus .a 684 to 1396 4 to 717       714/717
(99 %)
15 diff
(98.0 %id)
BM457352 embryonal carcinoma, cell line, testis .a 697 to 1694 1 to 1013       1013/1035
(97 %)
33 diff
(96.9 %id)
AW246967 lung, small cell carcinoma .a 700 to 1192 11 to 503     Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 495/503
(98 %)
9 diff
(98.3 %id)
BG420846 Kidney, renal cell adenocarcinoma .a 704 to 1451 1 to 747       747/975
(76 %)
29 diff
(97.1 %id)
BE018994 Kidney, renal cell adenocarcinoma .a 706 to 1245 1 to 540       540/540
(100 %)
2 diff
(99.7 %id)
BG575227 breast, mammary adenocarcinoma, cell line .a 728 to 1538 1 to 814       814/815
(99 %)
15 diff
(98.2 %id)
CB141821 Liver .a 737 to 1160 1 to 424       424/424
(100 %)
0 diff
(100 %id)
BU146033 dorsal root ganglia .a 764 to 1638 29 to 911       883/976
(90 %)
56 diff
(94.3 %id)
BQ054934 lymph, lymphoma, cell line .a 770 to 1731 1 to 961       961/1050
(91 %)
16 diff
(98.5 %id)
BG830652 epithelioid carcinoma cell line, Pancreas .a 795 to 1564 1 to 770       770/806
(95 %)
18 diff
(97.8 %id)
DA880914   .a 859 to 1404 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA392192 thalamus .a 862 to 1447 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BM751112 Ascites, stomach .a 862 to 1380 1 to 519       519/519
(100 %)
0 diff
(100 %id)
DA751154   .a 869 to 1425 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA358668 subthalamic nucleus .a 883 to 1447 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BI087484 cervix .a 892 to 1611 61 to 796       734/796
(92 %)
23 diff
(97.2 %id)
CN394855 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 893 to 1116 1 to 224       224/224
(100 %)
0 diff
(100 %id)
BM564099 blood, natural killer cells, cell line .a 936 to 1733 1 to 798       798/1112
(71 %)
17 diff
(98.5 %id)
BQ957559 large cell carcinoma, lung .a 941 to 1868 1 to 933       933/934
(99 %)
12 diff
(98.8 %id)
BU182595 leiomyosarcoma, uterus .a 970 to 1822 1 to 860       860/865
(99 %)
16 diff
(98.2 %id)
BG257766 embryonal carcinoma, cell line, testis .a 992 to 1801 1 to 808       808/917
(88 %)
25 diff
(97.3 %id)
BQ055672 lymph, lymphoma, cell line .a 1015 to 1820 1 to 822       822/1067
(77 %)
19 diff
(98.3 %id)
BQ066127 lymph, lymphoma, cell line .a 1015 to 1869 1 to 862       862/1068
(80 %)
10 diff
(99.1 %id)
BQ278973 adenocarcinoma, cell line, breast .a 1021 to 1768 1 to 754       754/900
(83 %)
10 diff
(98.9 %id)
DR760600 embryonic stem .a 1046 to 1803 1 to 757       757/757
(100 %)
1 diff
(99.9 %id)
BQ647267 hepatocellular carcinoma, cell line, Liver .a 1064 to 1786 1 to 734       734/837
(87 %)
12 diff
(98.6 %id)
BE082389 breast .a 1065 to 1587 525 to 3     Submitted on the opposite strand 523/566
(92 %)
5 diff
(99.2 %id)
BE082391 breast .a 1066 to 1587 523 to 3     Submitted on the opposite strand 521/565
(92 %)
5 diff
(99.2 %id)
BE786911 large cell carcinoma, lung .a 1067 to 1761 5 to 702       700/950
(73 %)
23 diff
(97.6 %id)
BF127893 leiomyosarcoma cell line, uterus .a 1067 to 1719 35 to 686       654/889
(73 %)
47 diff
(94.8 %id)
BI862515 breast, mammary adenocarcinoma, cell line .a 1085 to 1713 1 to 632       632/632
(100 %)
6 diff
(99.1 %id)
BM012542 brain, neuroblastoma, cell line .a 1085 to 1845 1 to 761       761/765
(99 %)
5 diff
(99.4 %id)
TI_57192694   .a 1085 to 1713 59 to 690       632/632
(100 %)
6 diff
(99.1 %id)
TI_59381760   .a 1086 to 1845 62 to 821       760/764
(99 %)
4 diff
(99.5 %id)
CN388329 embryonic stem cells, DMSO-treated H9 cellline .a 1096 to 1445 1 to 351       351/351
(100 %)
1 diff
(99.8 %id)
BQ671711 epidermoid carcinoma, cell line, salivary gland .a 1096 to 1993 18 to 919       902/924
(97 %)
24 diff
(97.5 %id)
BQ673650 epidermoid carcinoma, cell line, salivary gland .a 1096 to 1869 12 to 797       786/984
(79 %)
30 diff
(97.0 %id)
BU175028 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1798 1 to 709       709/949
(74 %)
22 diff
(97.7 %id)
BQ670181 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1947 1 to 859       859/867
(99 %)
12 diff
(98.7 %id)
BQ672878 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1919 1 to 835       835/902
(92 %)
33 diff
(96.4 %id)
BQ670720 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1872 1 to 783       783/985
(79 %)
11 diff
(98.9 %id)
BQ669860 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1935 1 to 845       845/961
(87 %)
27 diff
(97.2 %id)
BQ673185 epidermoid carcinoma, cell line, salivary gland .a 1097 to 2058 1 to 963       963/982
(98 %)
25 diff
(97.5 %id)
BQ672133 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1983 1 to 907       907/931
(97 %)
33 diff
(96.5 %id)
BQ670239 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1933 1 to 840       840/942
(89 %)
22 diff
(97.7 %id)
BQ675282 epidermoid carcinoma, cell line, salivary gland .a 1097 to 2022 1 to 935       935/935
(100 %)
16 diff
(98.3 %id)
BQ669437 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1833 1 to 745       745/901
(82 %)
24 diff
(97.4 %id)
BQ674315 epidermoid carcinoma, cell line, salivary gland .a 1097 to 2018 1 to 926       926/930
(99 %)
31 diff
(96.7 %id)
BQ670563 epidermoid carcinoma, cell line, salivary gland .a 1097 to 1930 1 to 843       843/909
(92 %)
15 diff
(98.4 %id)
BE082393 breast .a 1100 to 1587 497 to 9     Submitted on the opposite strand 489/497
(98 %)
0 diff
(100 %id)
BM470361 melanotic melanoma, skin .a 1102 to 1742 12 to 653       642/1072
(59 %)
13 diff
(98.8 %id)
DB113041 thymus .a 1103 to 1672 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE279119 choriocarcinoma, placenta .a 1112 to 1502 284 to 679       396/680
(58 %)
18 diff
(97.4 %id)
AW953625   .a 1126 to 1619 1 to 495       495/530
(93 %)
14 diff
(97.4 %id)
AA358622 lung .a 1127 to 1468 1 to 342       342/342
(100 %)
0 diff
(100 %id)
DA778728 brain .a 1138 to 1711 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BF317259 brain, neuroblastoma .a 1154 to 1794 7 to 666       662/989
(66 %)
32 diff
(96.8 %id)
BF982527 duodenal adenocarcinoma, cell line, small intestine .a 1155 to 1880 1 to 719       719/932
(77 %)
15 diff
(98.4 %id)
DB488224 hypothalamus .a 1157 to 1574 420 to 3     Submitted on the opposite strand 418/443
(94 %)
6 diff
(98.7 %id)
BG036981 brain, hypothalamus .a 1166 to 1760 1 to 595       595/871
(68 %)
7 diff
(99.2 %id)
BQ231033 leiomyosarcoma, uterus .a 1166 to 2187 1 to 1019       1019/1020
(99 %)
19 diff
(98.2 %id)
BE313379 brain, neuroblastoma .a 1168 to 1459 1 to 292       292/292
(100 %)
1 diff
(99.7 %id)
BE382492 brain, neuroblastoma .a 1170 to 1909 1 to 734       734/745
(98 %)
25 diff
(96.7 %id)
BF794776 lymph, lymphoma, cell line .a 1180 to 1933 1 to 749       749/980
(76 %)
15 diff
(98.5 %id)
AA356909   .a 1186 to 1390 1 to 205       205/208
(98 %)
2 diff
(99.1 %id)
DA737947   .a 1188 to 2054 2 to 867   capped   866/867
(99 %)
10 diff
(98.9 %id)
DA576197   .a 1196 to 1751 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BE515276 endometrium, adenocarcinoma cell line, uterus .a 1200 to 2000 29 to 829       801/829
(96 %)
11 diff
(98.7 %id)
DA295254 hippocampus .a 1205 to 1777 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BE393468 endometrium, adenocarcinoma cell line, uterus .a 1211 to 1862 1 to 662       662/690
(95 %)
25 diff
(96.4 %id)
DA295095 hippocampus .a 1212 to 1774 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BQ425414 eye, retinoblastoma .a 1212 to 2097 1 to 890       890/902
(98 %)
10 diff
(98.9 %id)
DB010957 colon, tumor tissue .a 1212 to 1761 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
TI_1948074804   .a 1224 to 1532 426 to 118   fully sequenced,   309/426
(72 %)
0 diff
(100 %id)
BE563013 endometrium, adenocarcinoma cell line, uterus .a 1227 to 1872 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BG026414 Bone, osteosarcoma, cell line .a 1228 to 2014 1 to 780       780/959
(81 %)
24 diff
(97.5 %id)
BQ071013 brain, neuroblastoma, cell line .a 1239 to 2099 1 to 862       862/980
(87 %)
6 diff
(99.4 %id)
BG027594 Bone, osteosarcoma, cell line .a 1240 to 2030 1 to 788       788/885
(89 %)
25 diff
(97.2 %id)
CV356961 kidney_tumor .a 1244 to 1841 644 to 42     Submitted on the opposite strand 605/645
(93 %)
36 diff
(94.5 %id)
BQ300456 bladder_tumor .a 1247 to 1662 21 to 438       421/438
(96 %)
12 diff
(97.3 %id)
DA419839 cord Blood .a 1247 to 1820 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
AU119869 whole embryo, mainly head .a 1263 to 2104 2 to 838   capped   837/840
(99 %)
7 diff
(99.2 %id)
AU131542   .a 1266 to 1998 19 to 756   capped   738/738
(100 %)
7 diff
(99.1 %id)
BE181127 head_neck .a 1271 to 1645 13 to 386       374/393
(95 %)
8 diff
(98.0 %id)
BF353188 head_neck .a 1271 to 1524 21 to 282       262/282
(92 %)
12 diff
(95.8 %id)
DA430574 colon .a 1292 to 1871 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BF182798 large cell carcinoma, lung .a 1294 to 2085 1 to 786       786/900
(87 %)
20 diff
(97.8 %id)
BE747034 adenocarcinoma cell line, ovary .a 1302 to 2086 1 to 778       778/821
(94 %)
17 diff
(98.0 %id)
CN388326 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1304 to 1926 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BF541736 hypernephroma, Kidney .a 1305 to 1964 1 to 656       656/659
(99 %)
10 diff
(98.5 %id)
DA606662   .a 1305 to 1876 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AW843879 colon_normal .a 1306 to 1847 543 to 1       543/543
(100 %)
4 diff
(99.3 %id)
BE175846 head_neck .a 1309 to 1680 30 to 401       372/401
(92 %)
8 diff
(98.1 %id)
AW844044 colon_normal .a 1314 to 1845 1 to 528       531/530
(100 %)
8 diff
(98.5 %id)
DA152285 amygdala .a 1315 to 1866 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG476030 melanotic melanoma, skin .a 1339 to 2083 11 to 760       750/1051
(71 %)
15 diff
(98.6 %id)
BG476296 melanotic melanoma, skin .a 1339 to 2071 11 to 747       737/910
(80 %)
16 diff
(98.3 %id)
BQ652807 hepatocellular carcinoma, cell line, Liver .a 1339 to 2244 12 to 936       925/942
(98 %)
32 diff
(96.7 %id)
AW673403 cervix .a 1342 to 1721 1 to 380       380/380
(100 %)
2 diff
(99.5 %id)
BG763291 melanotic melanoma, high MDR (cell line), skin .a 1345 to 2076 1 to 738       738/742
(99 %)
10 diff
(98.7 %id)
BG763630 melanotic melanoma, high MDR (cell line), skin .a 1345 to 2080 1 to 737       737/891
(82 %)
4 diff
(99.6 %id)
EC508092 Prostate .a 1348 to 1445 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
BE727900 melanotic melanoma, skin .a 1350 to 2062 1 to 718       718/824
(87 %)
14 diff
(98.4 %id)
DA621726 Kidney .a 1356 to 1892 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
BG116460 duodenal adenocarcinoma, cell line, small intestine .a 1362 to 2062 1 to 702       702/720
(97 %)
25 diff
(96.6 %id)
BF307378 muscle, rhabdomyosarcoma .a 1364 to 2085 1 to 717       717/919
(78 %)
16 diff
(98.3 %id)
BG826579 muscle, rhabdomyosarcoma .a 1365 to 2154 1 to 788       788/788
(100 %)
7 diff
(99.2 %id)
BE744426 adenocarcinoma cell line, ovary .a 1367 to 2187 1 to 824       824/918
(89 %)
30 diff
(96.8 %id)
BI261508 lymph, lymphoma, cell line .a 1371 to 2080 1 to 714       714/737
(96 %)
7 diff
(99.1 %id)
BU173303 leiomyosarcoma, uterus .a 1373 to 2258 1 to 887       887/899
(98 %)
12 diff
(98.7 %id)
BI085487 astrocytoma grade IV, cell line, brain .a 1387 to 1999 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BM020453 astrocytoma grade IV, cell line, brain .a 1387 to 2031 1 to 645       645/884
(72 %)
3 diff
(99.7 %id)
TI_59391240   .a 1388 to 2031 101 to 744       644/883
(72 %)
3 diff
(99.7 %id)
BQ270686 insulinoma, Pancreas .a 1403 to 1955 8 to 561       554/561
(98 %)
6 diff
(99.0 %id)
AL120043 amygdala .a 1407 to 1941 1 to 535       535/535
(100 %)
0 diff
(100 %id)
CF142245 CNCAP(3)T-225 cell line, Prostate .a 1416 to 1789 1 to 374       374/374
(100 %)
6 diff
(98.4 %id)
TI_154173156   .a 1423 to 1968 78 to 631       554/664
(83 %)
22 diff
(96.7 %id)
BQ217285 melanotic melanoma, skin .a 1429 to 2268 21 to 863       843/864
(97 %)
11 diff
(98.8 %id)
BC015559 Placenta, choriocarcinoma .a 1430 to 3395 3067 to 1103   AAA Submitted on the opposite strand 1965/3566
(55 %)
0 diff
(100 %id)
BE734549 choriocarcinoma, placenta .a 1432 to 2212 34 to 800       767/969
(79 %)
34 diff
(96.5 %id)
DB482595 hippocampus .a 1435 to 1927 1 to 493       493/494
(99 %)
1 diff
(99.8 %id)
N56490   .a 1443 to 1582 1 to 139       139/141
(98 %)
8 diff
(94.4 %id)
EC489881 Prostate .a 1474 to 1572 97 to 3       95/97
(97 %)
0 diff
(100 %id)
EC504190 Prostate .a 1474 to 1573 98 to 1       98/98
(100 %)
2 diff
(98.0 %id)
EC562379 Prostate .a 1474 to 1573 97 to 1       97/97
(100 %)
3 diff
(97.0 %id)
EC568394 Prostate .a 1474 to 1573 99 to 1       99/99
(100 %)
1 diff
(99.0 %id)
BG696641 skin .a 1479 to 2337 1 to 868       868/868
(100 %)
25 diff
(97.2 %id)
DA259286 caudate nucleus .a 1481 to 2030 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN388325 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1488 to 1898 9 to 419       411/419
(98 %)
6 diff
(98.6 %id)
BE019221 muscle, rhabdomyosarcoma .a 1502 to 1834 1 to 333       333/333
(100 %)
0 diff
(100 %id)
DA976196 synovial membrane tissue from rheumatioidarthritis .a 1514 to 2061 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
BE299980 muscle, rhabdomyosarcoma .a 1520 to 2331 1 to 799       799/873
(91 %)
26 diff
(97.1 %id)
BG292472 bladder, transitional cell papilloma, cell line .a 1525 to 2171 1 to 649       649/930
(69 %)
29 diff
(96.9 %id)
CD704419 normal nasopharynx .a 1534 to 1931 31 to 428       398/428
(92 %)
6 diff
(98.6 %id)
AA093862   .a 1563 to 1847 1 to 283       283/283
(100 %)
3 diff
(99.0 %id)
BM555110 duodenal adenocarcinoma, cell line, small intestine .a 1582 to 2626 1 to 1059       1059/1076
(98 %)
48 diff
(95.6 %id)
DA045647 bladder .a 1610 to 2188 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
T33808 brain .a 1638 to 2020 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
AA488942.
matches multiple genes
germinal center B cell .a 1645 to 2071 1 to 427     also hits gene INPP5D 427/427
(100 %)
0 diff
(100 %id)
AL569571 placenta .a 2259 to 3069 1094 to 291       804/1148
(70 %)
0 diff
(100 %id)
BF967842 brain, hypothalamus .a 2690 to 3348 690 to 24       667/692
(96 %)
0 diff
(100 %id)
BE300083 muscle, rhabdomyosarcoma .a 2702 to 3373 700 to 17       684/1084
(63 %)
0 diff
(100 %id)
AW675753 cervix .a 2827 to 3388 562 to 1       562/562
(100 %)
4 diff
(99.3 %id)
DB370565   .a 2837 to 3387 554 to 1       554/554
(100 %)
17 diff
(97.0 %id)
DB368575   .a 2851 to 3387 541 to 1       541/541
(100 %)
14 diff
(97.5 %id)
DB358416 whole embryo, mainly head .a 2893 to 3387 494 to 1       494/518
(95 %)
18 diff
(96.6 %id)
BI262125 lymph, lymphoma, cell line .a 2909 to 3339 437 to 1       437/645
(67 %)
17 diff
(97.4 %id)
BE206686 Kidney, renal cell adenocarcinoma .a 2915 to 3391 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AW250167 lung, small cell carcinoma .a 2923 to 3387 475 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 465/465
(100 %)
1 diff
(99.8 %id)
BM470773 eye, retinoblastoma .b 1 to 769 1 to 776 R10P D231* tiling clone,   776/948
(81 %)
12 diff
(98.8 %id)
BG395963 eye, retinoblastoma .b 125 to 769 1 to 654   tiling clone,   655/975
(67 %)
32 diff
(96.8 %id)
DA490434 brain .c 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
CB988280 Human Placenta, placenta .c 21 to 677 28 to 689 W91M D92G A93C L94P V95G ... tiling clone,   750/801
(93 %)
34 diff
(95.8 %id)
DA388620 thalamus .c 25 to 602 2 to 579   tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
DA538400 Kidney .c 25 to 618 2 to 596   tiling clone, capped   595/595
(100 %)
2 diff
(99.7 %id)
BI226086 Burkitt lymphoma, lymph .c 27 to 628 1 to 609       609/839
(72 %)
18 diff
(97.9 %id)
AW732307 Kidney, renal cell adenocarcinoma .c 36 to 593 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AK094925 corpus callosum .d 1 to 2948 2 to 2949 exact tiling clone, available from FLJ,   2949/2949
(100 %)
3 diff
(99.9 %id)
DA281759 corpus callosum .d 1 to 564 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DB136906 thymus .d 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
DB307355 corpus callosum .d 2418 to 2948 532 to 1       532/532
(100 %)
3 diff
(99.5 %id)
BU627645 Bone, Enchondroma cell line .e-u 1 to 684 702 to 19 L61I tiling clone, AAA   684/684
(100 %)
3 diff
(99.6 %id)
AI086408 anaplastic oligodendroglioma, brain .e-u 254 to 677 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AW137399   .e-u 274 to 678 422 to 18   tiling clone, AAA   405/405
(100 %)
3 diff
(99.3 %id)
AI873580 anaplastic oligodendroglioma, brain .e-u 306 to 643 338 to 1       338/338
(100 %)
0 diff
(100 %id)
BQ027269 mixed .e-u 408 to 681 292 to 19   AAA   274/274
(100 %)
0 diff
(100 %id)
AK023234   .f 1 to 2633 2 to 2635 R30P tiling clone, available from FLJ,   2635/2635
(100 %)
6 diff
(99.8 %id)
AU132114   .f 1 to 752 2 to 756 R30P capped   755/755
(100 %)
9 diff
(98.9 %id)
AW370546 breast .f 877 to 1445 1 to 568       568/570
(99 %)
5 diff
(99.2 %id)
AW370548 breast .f 888 to 1439 13 to 563       551/563
(97 %)
6 diff
(99.0 %id)
BE394949 endometrium, adenocarcinoma cell line, uterus .f 895 to 1567 1 to 667       667/682
(97 %)
36 diff
(94.8 %id)
BF817653 colon_ins .f 900 to 1266 396 to 29     Submitted on the opposite strand 368/397
(92 %)
0 diff
(100 %id)
BG779775 adenocarcinoma, Prostate .f 903 to 1668 1 to 782       782/813
(96 %)
36 diff
(95.6 %id)
DA704103   .f 903 to 1473 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BE742872 adenocarcinoma cell line, ovary .f 904 to 1513 1 to 613       613/875
(70 %)
16 diff
(98.2 %id)
BM019582 astrocytoma grade IV, cell line, brain .f 916 to 1329 1 to 415       415/890
(46 %)
5 diff
(99.5 %id)
TI_59390271   .f 917 to 1329 194 to 607       414/889
(46 %)
5 diff
(99.5 %id)
BG260139 bladder, transitional cell papilloma, cell line .f 929 to 1414 1 to 493       493/567
(86 %)
12 diff
(97.9 %id)
BQ648703 hepatocellular carcinoma, cell line, Liver .f 929 to 1784 1 to 859       859/859
(100 %)
19 diff
(97.8 %id)
BG290719 bladder, transitional cell papilloma, cell line .f 938 to 1690 1 to 753       753/1028
(73 %)
40 diff
(96.2 %id)
CF552049 Pooled muscle (cardiac and skeletal) .f 939 to 1786 1 to 846       846/846
(100 %)
3 diff
(99.7 %id)
CR749695 melanoma (MeWo cell line) .f 944 to 2635 1 to 1692   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1692/1692
(100 %)
1 diff
(100.0 %id)
BM475709 embryonal carcinoma, cell line, testis .f 950 to 1747 119 to 931       813/1054
(77 %)
38 diff
(96.4 %id)
BI061336 uterus_tumor .f 959 to 1345 69 to 458       390/459
(84 %)
15 diff
(96.8 %id)
CA395338 eye, RPE/choroid .f 962 to 1470 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
BU527426 epidermoid carcinoma, cell line, lung .f 963 to 1685 1 to 735       735/840
(87 %)
15 diff
(98.3 %id)
CD243297 brain, Pituitary .f 979 to 1645 33 to 711   AAA   679/1019
(66 %)
18 diff
(98.3 %id)
AI525067 Prostate .f 983 to 1339 15 to 374       360/755
(47 %)
9 diff
(98.9 %id)
DB488981 hypothalamus .f 983 to 1426 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
T06960   .f 989 to 1312 324 to 1       324/324
(100 %)
0 diff
(100 %id)
BG706859 brain, hypothalamus .f 996 to 1865 1 to 867       867/870
(99 %)
29 diff
(96.7 %id)
BI599360 brain, hypothalamus .f 996 to 1706 1 to 715       715/716
(99 %)
15 diff
(98.0 %id)
TI_59393953   .f 997 to 1835 88 to 935       848/873
(97 %)
27 diff
(97.0 %id)
BM015690 breast, mammary adenocarcinoma, cell line .f 998 to 1835 1 to 847       847/872
(97 %)
27 diff
(97.0 %id)
CN388328 embryonic stem cells, cell lines H1, H7, andH9 .f 1000 to 1640 36 to 677       642/677
(94 %)
6 diff
(99.2 %id)
TI_45211490   .f 1000 to 1706 84 to 794       711/795
(89 %)
13 diff
(98.4 %id)
CB159086 Liver .f 1021 to 1633 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BU526735 epidermoid carcinoma, cell line, lung .f 1023 to 1917 1 to 903       903/945
(95 %)
14 diff
(98.6 %id)
D56196   .f 1038 to 1324 1 to 287       287/287
(100 %)
0 diff
(100 %id)
TI_57187996   .f 1042 to 1657 75 to 699       625/844
(74 %)
21 diff
(97.6 %id)
BQ674459 epidermoid carcinoma, cell line, salivary gland .f 1059 to 1937 1 to 881       881/881
(100 %)
10 diff
(98.9 %id)
CX783507 human embryonic stem cells .f 1059 to 1854 1 to 795       795/795
(100 %)
1 diff
(99.9 %id)
AW860947 colon .f 1065 to 1636 575 to 4       572/575
(99 %)
0 diff
(100 %id)
CR609652 Neuroblastoma Cot 25-normalized .f 1091 to 2606 1 to 1516       1516/1516
(100 %)
0 diff
(100 %id)
BQ677676 melanotic melanoma, cell line, skin .f 1092 to 2006 1 to 936       936/945
(99 %)
34 diff
(96.5 %id)
BQ681385 melanotic melanoma, cell line, skin .f 1092 to 1988 1 to 920       920/944
(97 %)
38 diff
(96.0 %id)
BQ432402 melanotic melanoma, skin .f 1100 to 1953 1 to 855       855/855
(100 %)
9 diff
(99.0 %id)
CU455606 epidermis .f 1119 to 1560 458 to 18     Submitted on the opposite strand 441/479
(92 %)
0 diff
(100 %id)
CN388324 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1123 to 1909 1 to 787       787/787
(100 %)
1 diff
(99.9 %id)
TI_59387132   .f 1133 to 1668 71 to 606       536/537
(99 %)
9 diff
(98.4 %id)
BM910499 astrocytoma grade IV, cell line, brain .f 1134 to 2076 1 to 954       954/1067
(89 %)
14 diff
(98.7 %id)
CD676097 eye, lens .f 1144 to 1761 1 to 618       618/618
(100 %)
0 diff
(100 %id)
F05786 brain, total brain .f 1196 to 1496 1 to 301       301/301
(100 %)
0 diff
(100 %id)
TI_57231366   .f 1206 to 2041 96 to 937       842/878
(95 %)
28 diff
(96.9 %id)
CD107841 brain, Pituitary .f 1257 to 2114 1 to 866       866/867
(99 %)
19 diff
(97.9 %id)
BU542945 carcinoma, cell line, Prostate .f 1278 to 2075 1 to 810       810/908
(89 %)
25 diff
(97.3 %id)
BU790279 Pancreas, Purified pancreatic islet .f 1313 to 1929 1 to 618       618/618
(100 %)
5 diff
(99.2 %id)
BG251159 adenocarcinoma, cell line, Liver .f 1320 to 2080 1 to 754       754/854
(88 %)
31 diff
(96.4 %id)
CA435064 lung, Lung Focal Fibrosis .f 1324 to 2081 1 to 758     Submitted on the opposite strand 758/758
(100 %)
3 diff
(99.7 %id)
T69944 lung .f 1351 to 1810 11 to 477     Submitted on the opposite strand 467/477
(97 %)
5 diff
(99.0 %id)
BQ881935 brain, neuroblastoma, cell line .f 1402 to 2306 1 to 906       906/907
(99 %)
7 diff
(99.3 %id)
BU509694 leiomyosarcoma, uterus .f 1405 to 2221 1 to 829       829/910
(91 %)
23 diff
(97.5 %id)
BM722527 eye, fetal eye .f 1406 to 2012 1 to 607   fully sequenced, Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 607/607
(100 %)
1 diff
(99.9 %id)
EC447450 Prostate .f 1468 to 1579 109 to 3       107/109
(98 %)
0 diff
(100 %id)
EC448091 Prostate .f 1468 to 1582 116 to 1       116/116
(100 %)
2 diff
(98.3 %id)
EC463187 Prostate .f 1468 to 1582 114 to 1       114/114
(100 %)
3 diff
(97.4 %id)
EC478708 Prostate .f 1468 to 1582 112 to 1       112/112
(100 %)
3 diff
(97.4 %id)
EC486907 Prostate .f 1502 to 1607 111 to 5       107/111
(96 %)
0 diff
(100 %id)
EC506568 Prostate .f 1502 to 1594 111 to 21       91/111
(81 %)
0 diff
(100 %id)
EC580080 Prostate .f 1517 to 1637 121 to 1       121/121
(100 %)
0 diff
(100 %id)
EC483207 Prostate .f 1525 to 1649 131 to 6       126/131
(96 %)
0 diff
(100 %id)
CD107446 brain, Pituitary .f 1530 to 2346 1 to 822       822/823
(99 %)
9 diff
(99.0 %id)
W94723 heart .f 1543 to 1964 1 to 422   fully sequenced,   422/422
(100 %)
2 diff
(99.6 %id)
BF987138 placenta_normal .f 1584 to 1816 233 to 1       233/379
(61 %)
3 diff
(99.3 %id)
BM722004 eye, fetal eye .f 1588 to 2101 1 to 514   fully sequenced, Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 514/514
(100 %)
0 diff
(100 %id)
AB075479   .f 1633 to 2640 1 to 1009       1009/1009
(100 %)
2 diff
(99.9 %id)
BU186081 epidermoid carcinoma, cell line, salivary gland .f 1656 to 2435 20 to 799       780/935
(83 %)
7 diff
(99.3 %id)
TI_59389640   .f 1659 to 2436 98 to 874       777/777
(100 %)
17 diff
(97.9 %id)
TI_59389911   .f 1659 to 2430 101 to 877       777/788
(98 %)
20 diff
(97.5 %id)
BG684089 B-cells, primary B-cells from tonsils (cell line) .f 1661 to 2527 1 to 866       866/955
(90 %)
27 diff
(97.2 %id)
AA452736   .f 1666 to 2058 1 to 392       392/392
(100 %)
5 diff
(98.8 %id)
F00149 leg muscle, skeletal muscle .f 1679 to 1845 1 to 167       167/167
(100 %)
2 diff
(98.9 %id)
Z24796 leg muscle, skeletal muscle .f 1680 to 1845 166 to 1       166/167
(99 %)
0 diff
(100 %id)
AA043004 uterus .f 1795 to 2055 1 to 261       261/261
(100 %)
0 diff
(100 %id)
AA371442 Prostate .f 1796 to 2053 1 to 258       258/258
(100 %)
0 diff
(100 %id)
FN165639 breast carcinoma .f 1799 to 1881 86 to 5     Submitted on the opposite strand 82/88
(93 %)
0 diff
(100 %id)
TI_149302849   .f 1802 to 2635 913 to 90   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 824/929
(88 %)
31 diff
(96.7 %id)
BG009164 placenta_normal .f 1807 to 2200 431 to 38       394/431
(91 %)
0 diff
(100 %id)
TI_154043915   .f 1817 to 2635 903 to 97   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 807/972
(83 %)
15 diff
(98.5 %id)
BQ445881 Knee, Osteoarthritic Cartilage .f 1820 to 2632 819 to 17   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 803/803
(100 %)
15 diff
(98.2 %id)
BF770487 epid_tumor .f 1832 to 2217 404 to 21     Submitted on the opposite strand 384/404
(95 %)
0 diff
(100 %id)
BF771080 epid_tumor .f 1832 to 2217 404 to 21     Submitted on the opposite strand 384/404
(95 %)
0 diff
(100 %id)
BF932820 nervous_tumor .f 1832 to 2125 294 to 2     Submitted on the opposite strand 293/294
(99 %)
0 diff
(100 %id)
BF934544 nervous_tumor .f 1832 to 2125 295 to 2     Submitted on the opposite strand 294/295
(99 %)
0 diff
(100 %id)
BF987137 placenta_normal .f 1832 to 1936 106 to 2       105/106
(99 %)
0 diff
(100 %id)
AA370279 Prostate .f 1839 to 2106 1 to 268       268/268
(100 %)
0 diff
(100 %id)
TI_227714661   .f 1841 to 2635 891 to 99   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 793/1002
(79 %)
9 diff
(99.2 %id)
CR606991 T cells (Jurkat cell line) Cot10-normalized .f 1842 to 2643 1 to 802   tiling clone,   802/802
(100 %)
0 diff
(100 %id)
AL558007 T cells from T cell leukemia .f 1842 to 2643 1 to 803       803/803
(100 %)
3 diff
(99.7 %id)
BM720456 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1850 to 2066 1 to 217   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 217/217
(100 %)
0 diff
(100 %id)
TI_149301719   .f 1852 to 2635 868 to 93   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 776/941
(82 %)
13 diff
(98.7 %id)
TI_149302522   .f 1876 to 2635 844 to 88   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 757/907
(83 %)
7 diff
(99.3 %id)
TI_154131843   .f 1876 to 2635 861 to 104   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 758/961
(78 %)
12 diff
(98.8 %id)
BM980702 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1876 to 2635 773 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 757/801
(94 %)
7 diff
(99.2 %id)
CA313190 Human Lung Epithelial cells, lung .f 1884 to 2635 766 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 750/751
(99 %)
3 diff
(99.7 %id)
BI094060 cervix .f 1907 to 2643 1 to 747       747/922
(81 %)
25 diff
(97.3 %id)
BQ014485 Chondrosarcoma, Left Pubic Bone .f 1907 to 2635 744 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 728/737
(98 %)
2 diff
(99.8 %id)
CD368469 Alveolar Macrophage, lung .f 1913 to 2635 738 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 722/728
(99 %)
1 diff
(99.9 %id)
BQ182245 Knee, Osteoarthritic Cartilage .f 1922 to 2635 731 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
TI_154163824   .f 1923 to 2635 808 to 93   AAA Submitted on the opposite strand 716/1363
(52 %)
41 diff
(97.0 %id)
CA411648 Knee, Osteoarthritic Cartilage .f 1928 to 2635 724 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 708/708
(100 %)
1 diff
(99.9 %id)
BU632754 cell lines, Chondrosarcoma .f 1928 to 2635 724 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 708/708
(100 %)
2 diff
(99.8 %id)
BM980039 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1931 to 2635 720 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 704/704
(100 %)
2 diff
(99.8 %id)
W94478 heart .f 1934 to 2344 415 to 1   fully sequenced,   415/415
(100 %)
2 diff
(99.6 %id)
BM980970 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1934 to 2635 717 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 701/701
(100 %)
1 diff
(99.9 %id)
TI_57152426   .f 1942 to 2380 32 to 462   AAA   431/516
(83 %)
18 diff
(96.6 %id)
BQ776215 Bone, Human Chondrosarcoma Cell Line .f 1961 to 2635 691 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 675/675
(100 %)
0 diff
(100 %id)
BM679035 eye, fetal eye .f 1982 to 2635 666 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 650/650
(100 %)
6 diff
(99.1 %id)
FN054057 breast carcinoma .f 2007 to 2072 66 to 1     Submitted on the opposite strand 66/66
(100 %)
0 diff
(100 %id)
BQ772047 Chondrosarcoma Grade II, Left Pelvis .f 2011 to 2635 643 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 625/641
(97 %)
0 diff
(100 %id)
BU740381 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2036 to 2152 132 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 117/117
(100 %)
1 diff
(99.2 %id)
BY999132   .f 2043 to 2452 1 to 410     Submitted on the opposite strand 410/411
(99 %)
2 diff
(99.6 %id)
TI_57193534   .f 2043 to 2610 22 to 592       571/571
(100 %)
14 diff
(97.6 %id)
BM678517 eye, fetal eye .f 2071 to 2635 582 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 565/565
(100 %)
1 diff
(99.9 %id)
TI_154091899   .f 2090 to 2450 95 to 456     Submitted on the opposite strand 362/668
(54 %)
9 diff
(98.7 %id)
BM984384 lung, Primary Lung Epithelial Cells .f 2103 to 2442 1 to 340     Submitted on the opposite strand 340/340
(100 %)
0 diff
(100 %id)
BU602600 mixed (pool of 40 RNAs) .f 2105 to 2633 563 to 38   AAA Submitted on the opposite strand 526/544
(96 %)
0 diff
(100 %id)
TI_151757885   .f 2105 to 2539 622 to 186       661/993
(66 %)
37 diff
(96.3 %id)
BM998883 lung, Lung Focal Fibrosis .f 2108 to 2257 1 to 150     Submitted on the opposite strand 150/150
(100 %)
3 diff
(98.0 %id)
CA434463 lung, Lung Focal Fibrosis .f 2108 to 2446 1 to 339     Submitted on the opposite strand 339/339
(100 %)
3 diff
(99.2 %id)
AU153719   .f 2109 to 2633 525 to 1       525/536
(97 %)
9 diff
(98.4 %id)
BM990993 lung, Lung Focal Fibrosis .f 2110 to 2609 3 to 503     Submitted on the opposite strand 501/511
(98 %)
5 diff
(99.1 %id)
BQ016838 lung, Lung Focal Fibrosis .f 2113 to 2440 1 to 326   AAA Submitted on the opposite strand 326/326
(100 %)
6 diff
(98.2 %id)
TI_154166891   .f 2116 to 2450 92 to 426       335/603
(55 %)
2 diff
(99.7 %id)
TI_154191859   .f 2120 to 2453 51 to 385       335/339
(98 %)
3 diff
(99.2 %id)
FN149547 breast carcinoma .f 2122 to 2214 96 to 1     Submitted on the opposite strand 96/97
(98 %)
4 diff
(95.9 %id)
FN090208 breast carcinoma .f 2123 to 2192 70 to 1     Submitted on the opposite strand 70/70
(100 %)
0 diff
(100 %id)
DB540200 hippocampus .f 2125 to 2635 1 to 513     Submitted on the opposite strand 513/513
(100 %)
3 diff
(99.5 %id)
FN067966 breast carcinoma .f 2126 to 2204 77 to 1     Submitted on the opposite strand 77/77
(100 %)
2 diff
(97.5 %id)
FN117711 breast carcinoma .f 2126 to 2234 110 to 1     Submitted on the opposite strand 110/110
(100 %)
2 diff
(98.2 %id)
FN129759 breast carcinoma .f 2126 to 2205 1 to 79       79/81
(97 %)
3 diff
(96.3 %id)
FN138897 breast carcinoma .f 2126 to 2207 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
FN160758 breast carcinoma .f 2126 to 2217 1 to 91       91/93
(97 %)
2 diff
(97.9 %id)
FN161549 breast carcinoma .f 2126 to 2221 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
FN173858 breast carcinoma .f 2126 to 2213 1 to 89       89/90
(98 %)
3 diff
(96.7 %id)
T70019 lung .f 2126 to 2346 228 to 7     Submitted on the opposite strand 222/228
(97 %)
0 diff
(100 %id)
TI_157603085   .f 2127 to 2641 647 to 125       523/1358
(38 %)
0 diff
(100 %id)
AW342135 gestational trophoblastic tissues .f 2128 to 2633 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CA439826 lung, Lung Focal Fibrosis .f 2131 to 2636 6 to 511     Submitted on the opposite strand 506/511
(99 %)
8 diff
(98.5 %id)
BQ010672 placenta .f 2132 to 2635 519 to 16   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 504/504
(100 %)
0 diff
(100 %id)
AI884921 anaplastic oligodendroglioma, brain .f 2136 to 2638 503 to 1       503/503
(100 %)
0 diff
(100 %id)
FN102382 breast carcinoma .f 2139 to 2258 122 to 1     Submitted on the opposite strand 122/122
(100 %)
2 diff
(98.4 %id)
BI088980 cervix .f 2140 to 2394 687 to 940       911/974
(93 %)
43 diff
(95.6 %id)
H38851 eye, retina .f 2141 to 2543 1 to 418     Submitted on the opposite strand 418/418
(100 %)
15 diff
(96.5 %id)
CA950068 Pancreas, Purified pancreatic islet .f 2142 to 2319 1 to 178   fully sequenced,   178/178
(100 %)
0 diff
(100 %id)
AI479859 anaplastic oligodendroglioma, brain .f 2143 to 2635 493 to 1       493/493
(100 %)
0 diff
(100 %id)
TI_157605111   .f 2146 to 2635 583 to 94   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 490/490
(100 %)
0 diff
(100 %id)
BE245529 leukopheresis .f 2147 to 2635 490 to 1       490/490
(100 %)
4 diff
(99.2 %id)
FN133586 breast carcinoma .f 2148 to 2261 113 to 1     Submitted on the opposite strand 113/121
(93 %)
3 diff
(97.6 %id)
AA316311 colon .f 2149 to 2633 1 to 485       485/485
(100 %)
0 diff
(100 %id)
DB551454 hippocampus .f 2149 to 2635 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
EL951140 eyeball .f 2153 to 2635 1 to 483   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 483/483
(100 %)
4 diff
(99.2 %id)
FN100512 breast carcinoma .f 2159 to 2272 108 to 1     Submitted on the opposite strand 108/108
(100 %)
4 diff
(96.3 %id)
AA833890 germinal center B cell .f 2162 to 2635 500 to 27   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 474/474
(100 %)
0 diff
(100 %id)
BU789982 Pancreas, Purified pancreatic islet .f 2167 to 2638 471 to 1       471/471
(100 %)
7 diff
(98.6 %id)
AI147687 brain, glioblastoma (pooled) .f 2169 to 2637 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BQ013304 placenta .f 2170 to 2635 482 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 466/466
(100 %)
0 diff
(100 %id)
FN159834 breast carcinoma .f 2172 to 2279 106 to 1     Submitted on the opposite strand 106/106
(100 %)
3 diff
(97.2 %id)
AA565004 adrenal adenoma, adrenal gland .f 2172 to 2641 470 to 1       470/470
(100 %)
0 diff
(100 %id)
DB558346 hypothalamus .f 2173 to 2635 1 to 465     Submitted on the opposite strand 465/465
(100 %)
6 diff
(98.8 %id)
H38610 eye, retina .f 2173 to 2621 455 to 2     Submitted on the opposite strand 454/456
(99 %)
0 diff
(100 %id)
H37936 eye, retina .f 2183 to 2621 451 to 2     Submitted on the opposite strand 450/490
(91 %)
0 diff
(100 %id)
AW438512 normal squamous epithelium from retromolartrigone .f 2184 to 2647 499 to 34       466/499
(93 %)
0 diff
(100 %id)
DB542836 hippocampus .f 2186 to 2635 1 to 450     Submitted on the opposite strand 450/450
(100 %)
1 diff
(99.8 %id)
BQ377691 uterus .f 2187 to 2383 228 to 34       195/230
(84 %)
11 diff
(95.3 %id)
DB549171 hippocampus .f 2187 to 2635 1 to 449     Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
AW014235   .f 2189 to 2635 464 to 18   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
AI041972 senescent fibroblast .f 2191 to 2641 451 to 1       451/451
(100 %)
0 diff
(100 %id)
FN164897 breast carcinoma .f 2195 to 2293 97 to 1     Submitted on the opposite strand 97/97
(100 %)
2 diff
(98.0 %id)
AI363367 brain, glioblastoma (pooled) .f 2195 to 2636 442 to 1       442/442
(100 %)
0 diff
(100 %id)
DB530715 hippocampus .f 2196 to 2635 1 to 441     Submitted on the opposite strand 441/441
(100 %)
26 diff
(94.2 %id)
CF135471 lymph .f 2197 to 2635 469 to 31   AAA Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
AI124091 heart .f 2198 to 2640 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI017231 Kidney .f 2200 to 2635 436 to 1       436/436
(100 %)
0 diff
(100 %id)
FN138471 breast carcinoma .f 2205 to 2291 85 to 1     Submitted on the opposite strand 85/85
(100 %)
2 diff
(97.7 %id)
AW273088 colon, moderately-differentiated adenocarcinoma .f 2208 to 2643 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BE208650 melanotic melanoma, skin .f 2214 to 2637 424 to 1   available from MGC,   424/424
(100 %)
4 diff
(99.1 %id)
FN142518 breast carcinoma .f 2215 to 2305 90 to 1     Submitted on the opposite strand 90/90
(100 %)
1 diff
(98.9 %id)
AI866181 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 2219 to 2636 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AI093332 uterus .f 2223 to 2635 436 to 24   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AA648310 germinal center B cell .f 2230 to 2643 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AA658369   .f 2231 to 2639 443 to 35   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 409/410
(99 %)
0 diff
(100 %id)
AW440901 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .f 2232 to 2635 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA042879 uterus .f 2237 to 2635 401 to 1       401/402
(99 %)
2 diff
(99.6 %id)
FN135683 breast carcinoma .f 2238 to 2325 88 to 5     Submitted on the opposite strand 84/91
(92 %)
0 diff
(100 %id)
CF529644 placenta .f 2238 to 2635 414 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
H38589 eye, retina .f 2239 to 2619 386 to 4     Submitted on the opposite strand 383/386
(99 %)
0 diff
(100 %id)
AI017009 Kidney .f 2258 to 2635 378 to 1       378/378
(100 %)
0 diff
(100 %id)
FN068592 breast carcinoma .f 2264 to 2329 66 to 1     Submitted on the opposite strand 66/66
(100 %)
0 diff
(100 %id)
FN069162 breast carcinoma .f 2268 to 2370 104 to 1     Submitted on the opposite strand 104/104
(100 %)
2 diff
(98.1 %id)
H86265 eye, retina .f 2268 to 2621 365 to 2     Submitted on the opposite strand 364/365
(99 %)
0 diff
(100 %id)
AA262554 germinal center B cell .f 2269 to 2636 369 to 1     Submitted on the opposite strand 369/375
(98 %)
5 diff
(98.7 %id)
AA878793 hepatic adenoma, Liver .f 2277 to 2642 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AI360950 brain, glioblastoma (pooled) .f 2277 to 2633 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA629234   .f 2281 to 2408 128 to 1       128/128
(100 %)
0 diff
(100 %id)
AA452551   .f 2281 to 2639 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
BI757067 brain .f 2288 to 2635 1 to 348   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
TI_57221615   .f 2288 to 2635 70 to 417   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 348/417
(83 %)
6 diff
(98.6 %id)
F37326 pectoral muscle (after mastectomy) .f 2288 to 2632 1 to 345       345/345
(100 %)
0 diff
(100 %id)
CA943865 Pancreas, Purified pancreatic islet .f 2289 to 2634 346 to 1   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
FN093629 breast carcinoma .f 2292 to 2394 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
FN151116 breast carcinoma .f 2297 to 2404 108 to 1     Submitted on the opposite strand 108/108
(100 %)
4 diff
(96.3 %id)
BM702861 eye, Retina Foveal and Macular .f 2299 to 2635 1 to 337   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 337/337
(100 %)
0 diff
(100 %id)
FN063133 breast carcinoma .f 2308 to 2393 1 to 85       85/92
(92 %)
2 diff
(97.9 %id)
FN175445 breast carcinoma .f 2312 to 2413 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
FN053584 breast carcinoma .f 2314 to 2417 107 to 1     Submitted on the opposite strand 107/107
(100 %)
4 diff
(96.3 %id)
AL134964 melanoma (MeWo cell line) .f 2319 to 2635 1 to 317   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
F27815 pectoral muscle (after mastectomy) .f 2321 to 2626 1 to 306       306/306
(100 %)
0 diff
(100 %id)
FN165834 breast carcinoma .f 2324 to 2419 95 to 1     Submitted on the opposite strand 95/98
(96 %)
7 diff
(92.9 %id)
FN125090 breast carcinoma .f 2331 to 2423 95 to 1     Submitted on the opposite strand 95/96
(98 %)
4 diff
(95.9 %id)
FN136369 breast carcinoma .f 2331 to 2423 92 to 1     Submitted on the opposite strand 92/93
(98 %)
1 diff
(99.0 %id)
FN072760 breast carcinoma .f 2341 to 2429 1 to 88       88/92
(95 %)
4 diff
(95.7 %id)
FN176128 breast carcinoma .f 2349 to 2441 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
BU609063 Human Lung Epithelial cells, lung .f 2350 to 2635 302 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
F02033 brain, total brain .f 2368 to 2635 268 to 1       268/268
(100 %)
2 diff
(99.3 %id)
AI018166 pooled .f 2371 to 2635 276 to 12   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 265/265
(100 %)
0 diff
(100 %id)
BI049148 uterus .f 2389 to 2511 13 to 134       122/134
(91 %)
6 diff
(95.6 %id)
EC471771 Prostate .f 2392 to 2469 1 to 78       78/78
(100 %)
4 diff
(94.9 %id)
EC473604 Prostate .f 2413 to 2488 9 to 84       76/84
(90 %)
8 diff
(90.5 %id)
FN092499 breast carcinoma .f 2428 to 2510 84 to 1     Submitted on the opposite strand 84/84
(100 %)
2 diff
(97.7 %id)
FN102385 breast carcinoma .f 2443 to 2520 79 to 1     Submitted on the opposite strand 79/82
(96 %)
1 diff
(98.8 %id)
EC526309 Prostate .f 2444 to 2530 1 to 87       87/87
(100 %)
0 diff
(100 %id)
AA632032 breast .f 2445 to 2628 184 to 1       184/184
(100 %)
0 diff
(100 %id)
FN056894 breast carcinoma .f 2450 to 2541 1 to 92       92/92
(100 %)
0 diff
(100 %id)
AL040496 testis .f 2466 to 2591 121 to 1     Submitted on the opposite strand 121/121
(100 %)
3 diff
(97.6 %id)
AW070570 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .f 2467 to 2635 185 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 169/169
(100 %)
0 diff
(100 %id)
AW238023 normal squamous epithelium from retromolartrigone .f 2467 to 2635 190 to 22   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 169/169
(100 %)
0 diff
(100 %id)
AW469052 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2467 to 2635 183 to 15   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 169/169
(100 %)
0 diff
(100 %id)
AI828485 adenocarcinoma, Pancreas .f 2478 to 2643 166 to 1       166/166
(100 %)
0 diff
(100 %id)
N63605 multiple sclerosis lesions .f 2508 to 2635 128 to 1       128/128
(100 %)
0 diff
(100 %id)
FN120249 breast carcinoma .f 2511 to 2609 98 to 2     Submitted on the opposite strand 97/98
(98 %)
0 diff
(100 %id)
AA583734 larynx .f 2525 to 2635 111 to 1       111/111
(100 %)
0 diff
(100 %id)
FN074974 breast carcinoma .f 2532 to 2599 71 to 3     Submitted on the opposite strand 69/75
(92 %)
0 diff
(100 %id)
FN092875 breast carcinoma .f 2533 to 2588 1 to 56       56/57
(98 %)
1 diff
(98.3 %id)
DA287289 corpus callosum .g 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
BM504456 insulinoma, Pancreas .h-u 1 to 545 8 to 552 exact     545/552
(98 %)
6 diff
(99.0 %id)
CK905503 insulinoma, Pancreas .h-u 1 to 432 8 to 439 exact tiling clone,   432/440
(98 %)
2 diff
(99.6 %id)
AW604286 colon .h-u 310 to 959 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
AW752756 colon .h-u 310 to 932 1 to 623       623/623
(100 %)
8 diff
(98.8 %id)
AW850611 colon .h-u 310 to 1041 1 to 732   tiling clone,   732/733
(99 %)
3 diff
(99.6 %id)
AW752791 colon .h-u 312 to 832 1 to 520       520/520
(100 %)
10 diff
(98.1 %id)
AW377033 colon .h-u 327 to 719 1 to 395       395/397
(99 %)
8 diff
(98.0 %id)
BM504239 insulinoma, Pancreas .h-u 375 to 967 609 to 17   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
AW850556 colon .h-u 408 to 1072 677 to 12       666/677
(98 %)
0 diff
(100 %id)
AW376975 colon .h-u 424 to 1065 642 to 1       642/642
(100 %)
2 diff
(99.7 %id)
AW604203 colon .h-u 443 to 1065 624 to 1       624/624
(100 %)
2 diff
(99.7 %id)
AW604200 colon .h-u 511 to 1065 556 to 1       556/556
(100 %)
2 diff
(99.7 %id)
AW604220 colon .h-u 533 to 1065 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
AW367596 head_neck .h-u 540 to 1076 554 to 19       536/554
(96 %)
0 diff
(100 %id)
TI_151720754   .h-u 569 to 987 78 to 495     Submitted on the opposite strand 418/697
(59 %)
6 diff
(99.2 %id)
BM720415 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 578 to 987 419 to 11     Submitted on the opposite strand 409/420
(97 %)
0 diff
(100 %id)
AI367533 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h-u 613 to 967 391 to 37   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 355/355
(100 %)
12 diff
(96.7 %id)
AW449393   .h-u 650 to 967 335 to 18   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 318/318
(100 %)
1 diff
(99.7 %id)
AW850691 colon .h-u 671 to 1210 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
AW604221 colon .h-u 784 to 1215 442 to 11   tiling clone,   432/442
(97 %)
0 diff
(100 %id)
AW367572 head_neck .h-u 798 to 1070 1 to 272       272/283
(96 %)
6 diff
(97.9 %id)
AW376867 colon .h-u 861 to 1210 350 to 1       350/350
(100 %)
5 diff
(98.6 %id)
DB132991 thymus .i-u 1 to 533 2 to 534 exact tiling clone, capped   533/533
(100 %)
0 diff
(100 %id)
DB252999 uterus .i-u 26 to 587 2 to 563 D24N L34S Q36P N37E G38W ... capped   562/562
(100 %)
3 diff
(99.5 %id)
DA960247 Spleen .i-u 336 to 899 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA383194 thalamus .i-u 447 to 974 2 to 530   tiling clone, capped   529/529
(100 %)
1 diff
(99.9 %id)
BX951645   .j-u 1 to 655 1 to 655 exact tiling clone,   655/655
(100 %)
0 diff
(100 %id)
BF335624 colon .j-u 487 to 838 1 to 349   tiling clone,   349/349
(100 %)
5 diff
(98.6 %id)
AI248747 liver and spleen .k 1 to 324 324 to 1 exact tiling clone,   324/324
(100 %)
0 diff
(100 %id)
AK096666   Gene STARD7, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BC007894 Brain, neuroblastoma Gene STARD7, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BC009998 Brain, neuroblastoma Gene STARD7, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
TI_57241045   Gene STARD7, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154154086   Gene STARD7, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h-u, .i-u, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C